Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 178 citing de Tejada: Effects of tadalafil on erectile dysfunction in men with diabetes. (0.08 sec) 

Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated …

- e-med.co.il [PDF] 
GB Brock, CG McMahon, KK Chen, T Costigan, … - The Journal of urology, 2002 - Elsevier
A total of 1,112 men with a mean age of 59 years (range 22 to 82) and mild to
severe erectile dysfunction of various etiologies were randomized to placebo or
tadalafil, taken as needed without food or alcohol restrictions, at fixed ...
Cited by 361 - Related articles - BL Direct - All 16 versions

Diabetic neuropathies

- diabetesjournals.org
AJM Boulton, AI Vinik, JC Arezzo, V Bril, EL … - Diabetes Care, 2005 - Am Diabetes Assoc
The diabetic neuropathies are heterogeneous, affecting different parts of the
nervous system that present with diverse clinical manifestations. They may be
focal or diffuse. Most common among the neuropathies are chronic ...
Cited by 337 - Related articles - All 11 versions

Diabetic neuropathy: an intensive review


JJ Duby, RK Campbell, SM Setter, JR White, … - American Journal of Health-System Pharmacy, 2004 - ASHP
160 Am J Health-Syst Pharm—Vol 61 Jan 15, 2004 ... J EREMIAH J OHN D UBY , R.
K EITH C AMPBELL , S TEPHEN M. S ETTER , ... J OHN R AYMOND W HITE , AND K
RISTIN A. R ASMUSSEN ... J EREMIAH J OHN D UBY , P HARM .D., is General ...
Cited by 150 - Related articles - BL Direct - All 9 versions

The efficacy and safety of tadalafil: an update


CC Carson, J Rajfer, I Eardley, S Carrier, … - BJU international, 2004 - interscience.wiley.com
In all, 2102 men (mean age 56 years) with mild-to-severe ED of various causes
were randomized to placebo or tadalafil, taken as needed with no food
restrictions, at fixed 'on-demand' doses of 10 or 20 mg in 11 randomized, ...
Cited by 135 - Related articles - BL Direct - All 10 versions

Overview of phosphodiesterase 5 inhibition in erectile dysfunction


RC Rosen, JB Kostis - The American journal of cardiology, 2003 - Elsevier
Since the early 1980s, research on the mechanisms of penile erection has done
much to clarify erectile physiology and pathophysiology. More recent studies
have identified the importance of neurochemical mediators in erection. ...
Cited by 88 - Related articles - All 4 versions

Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: …

- pubget.com [PDF] 
V Fonseca, A Seftel, J Denne, P Fredlund - Diabetologia, 2004 - Springer
Aims/hypothesis. A retrospective analysis of pooled data from twelve
placebo-controlled trials was conduct- ed to characterise the efficacy and
safety of tadalafil for the treatment of erectile dysfunction in men with ...
Cited by 81 - Related articles - All 4 versions

Phosphodiesterase type 5 inhibitors for erectile dysfunction


CC Carson, TF Lue - BJU International-British Journal of Urology, 2005 - bjui.org
The cyclic nucleotide signalling pathway mediates the smooth-muscle relaxing
effects of nitric oxide necessary for normal erectile function. Down-regulation
of this pathway is central to the pathophysiology of many forms of erectile ...
Cited by 74 - Related articles - BL Direct - All 5 versions

Erectile dysfunction: management update

- canadianmedicaljournal.ca
L Fazio, G Brock - Canadian Medical Association Journal, 2004 - canadianmedicaljournal.ca
DRAMATIC ADVANCES IN THE MANAGEMENT of erectile dysfunction have occurred over
the past decade. Oral therapy with vasoactive agents has emerged as first-line
treatment and has transformed both the manner in which the public views ...
Cited by 76 - Related articles - BL Direct - All 16 versions

Guidelines on erectile dysfunction

- dsb.ro [PDF] 
E Wespes, E Amar, D Hatzichristou, F Montorsi … - European urology, 2002 - Elsevier
Male erectile dysfunction (ED) (impotence) has been defined as the persistent
(lasting for at least 6 months) inability to attain and maintain an erection
sufficient to permit satisfactory sexual performance. Although ED is a ...
Cited by 71 - Related articles - BL Direct - All 28 versions

Switching patients with erectile dysfunction from sildenafil citrate to tadalafil: results of a …


P Ströberg, A Murphy, T Costigan - Clinical therapeutics, 2003 - Elsevier
Methods: This was a short-term, multicenter, open-label, 1-way crossover trial
conducted in Sweden and Italy. Eligible patients included men aged ≥18 years
with a minimum 3-month history of ED who had been taking sildenafil at ...
Cited by 71 - Related articles - All 4 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google